Primary |
Drug Use For Unknown Indication |
100.0% |
|
Loss Of Consciousness |
100.0% |
|
Secondary |
Epilepsy |
32.9% |
Product Used For Unknown Indication |
9.0% |
Supraventricular Tachycardia |
6.1% |
Chronic Obstructive Pulmonary Disease |
5.2% |
Dermatitis |
5.2% |
Drug Use For Unknown Indication |
4.8% |
Maternal Exposure Timing Unspecified |
3.8% |
Grand Mal Convulsion |
3.6% |
Rash |
3.6% |
Thrombosis Prophylaxis |
3.6% |
Convulsion |
3.1% |
Sleep Disorder |
3.1% |
Tachycardia Paroxysmal |
3.1% |
Drug Exposure During Pregnancy |
2.6% |
Hypothyroidism |
2.1% |
Conjunctivitis |
1.7% |
Nausea |
1.7% |
Pruritus |
1.7% |
Prophylaxis Of Neural Tube Defect |
1.6% |
Vomiting |
1.4% |
|
Toxic Epidermal Necrolysis |
13.7% |
Spina Bifida |
12.3% |
Suicide Attempt |
11.0% |
Ventricular Septal Defect |
8.2% |
Weight Decreased |
6.8% |
Epilepsy |
5.5% |
Product Quality Issue |
5.5% |
Convulsion |
4.1% |
Maternal Drugs Affecting Foetus |
4.1% |
Weight Increased |
4.1% |
Drug Exposure During Pregnancy |
2.7% |
Exposure During Pregnancy |
2.7% |
Multiple Drug Overdose Intentional |
2.7% |
Restlessness |
2.7% |
Speech Disorder |
2.7% |
Stevens-johnson Syndrome |
2.7% |
Thrombocytopenia |
2.7% |
Wrong Drug Administered |
2.7% |
Amenorrhoea |
1.4% |
Cardiac Aneurysm |
1.4% |
|
Concomitant |
Epilepsy |
49.2% |
Product Used For Unknown Indication |
9.4% |
Drug Use For Unknown Indication |
9.0% |
Convulsion |
7.1% |
Prophylaxis |
3.0% |
Glioblastoma |
2.7% |
Premedication |
2.7% |
Depression |
2.5% |
Partial Seizures |
2.0% |
Infection |
1.9% |
Acute Myeloid Leukaemia |
1.4% |
Anxiety |
1.2% |
Grand Mal Convulsion |
1.2% |
Status Epilepticus |
1.1% |
Autoimmune Thrombocytopenia |
1.0% |
Hypothyroidism |
1.0% |
Hypertension |
0.9% |
Hypokalaemia |
0.8% |
Multiple Sclerosis |
0.8% |
Systemic Lupus Erythematosus |
0.8% |
|
Somnolence |
9.4% |
Status Epilepticus |
8.7% |
Vomiting |
8.7% |
Weight Decreased |
6.3% |
Convulsion |
5.5% |
Pyrexia |
5.5% |
Transaminases Increased |
5.5% |
Urinary Tract Infection |
5.5% |
Pregnancy |
4.7% |
Restlessness |
4.7% |
Disease Progression |
3.9% |
Encephalopathy |
3.9% |
Epilepsy |
3.9% |
Fatigue |
3.9% |
Weight Increased |
3.9% |
Fall |
3.1% |
Hepatic Cirrhosis |
3.1% |
Malaise |
3.1% |
Partial Seizures |
3.1% |
Rash |
3.1% |
|